Skip to content

EV / sales at other companies

Intuitive Surgical logo
Intuitive SurgicalISRG
19.6×-2.4×
Bioventus logo
BioventusBVS
1.5×-0.2×
Globus Medical logo
Globus MedicalGMED
3.6×-0.2×

Other financials

Income statement

See full
Revenue$5.3M+104%
Gross profit$3.8M+107%
Operating income-$8.0M+28.2%
Net income-$7.1M+34.2%
EPS (diluted)$0.19-47.2%

Balance sheet

See full
Cash & equivalents$50.3M+8.3%
Total debt$7.5M+52.8%
Total equity$59.4M+17.0%
Total assets$73.5M+20.7%

Cash flow

See full
Operating cash flow-$8.6M-3.6%
CapEx$44.0K
Free cash flow-$9.6M

Valuation

See full
Market cap$241.65M+30.7%
Enterprise value$198.81M+28.7%
P/S12.8×-2.8×

Profitability

See full
Gross margin71.1%+3.4pp
Operating margin-202.6%-51.3pp
Net margin-206.8%-39.0pp
FCF margin-238.4%

Returns & leverage

See full
Return on equity-70.6%+4.8pp
Debt / equity0.1×0.0×
Current ratio6.6×-4.8×

Where this comes from

Calculated from Profound Medical’s reported figures.

Based on the most recent quarter.

The official record: Profound Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Profound Medical's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Profound Medical's EV / sales?
Profound Medical (PROF) reported EV / sales of 10.2× in Q1 2026.
How has Profound Medical's EV / sales changed year-over-year?
Profound Medical's EV / sales decreased by 9.0% year-over-year, from 11.2× to 10.2×.
What is the long-term trend for Profound Medical's EV / sales?
Over 2 years (2023 to 2025), Profound Medical's EV / sales has grown at a -21.7% compound annual growth rate (CAGR), from 22.6× to 13.9×.
What does EV / sales mean?
Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.